NO980803D0 - Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem - Google Patents

Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem

Info

Publication number
NO980803D0
NO980803D0 NO980803A NO980803A NO980803D0 NO 980803 D0 NO980803 D0 NO 980803D0 NO 980803 A NO980803 A NO 980803A NO 980803 A NO980803 A NO 980803A NO 980803 D0 NO980803 D0 NO 980803D0
Authority
NO
Norway
Prior art keywords
new
alkyl
processes
preparation
pharmaceutical compositions
Prior art date
Application number
NO980803A
Other languages
English (en)
Other versions
NO314307B1 (no
NO980803L (no
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO980803D0 publication Critical patent/NO980803D0/no
Publication of NO980803L publication Critical patent/NO980803L/no
Publication of NO314307B1 publication Critical patent/NO314307B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19980803A 1997-02-27 1998-02-26 Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem NO314307B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO980803D0 true NO980803D0 (no) 1998-02-26
NO980803L NO980803L (no) 1998-08-28
NO314307B1 NO314307B1 (no) 2003-03-03

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980803A NO314307B1 (no) 1997-02-27 1998-02-26 Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem

Country Status (19)

Country Link
US (1) US5968954A (no)
EP (1) EP0861837B1 (no)
JP (1) JPH10237071A (no)
CN (1) CN1090627C (no)
AT (1) ATE265451T1 (no)
AU (1) AU725756B2 (no)
BR (1) BR9800763A (no)
CA (1) CA2231025C (no)
DE (1) DE69823411T2 (no)
DK (1) DK0861837T3 (no)
ES (1) ES2219853T3 (no)
FR (1) FR2760014B1 (no)
HK (1) HK1014945A1 (no)
HU (1) HU224312B1 (no)
NO (1) NO314307B1 (no)
NZ (1) NZ329853A (no)
PL (1) PL190240B1 (no)
PT (1) PT861837E (no)
ZA (1) ZA981680B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022228A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
AU2002217742B2 (en) 2001-01-16 2008-02-21 Astrazeneca Ab Therapeutic heterocyclic compounds
WO2003007956A1 (en) 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006062063A1 (ja) * 2004-12-08 2008-06-12 アステラス製薬株式会社 ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2760014B1 (fr) 1999-04-09
ES2219853T3 (es) 2004-12-01
HU9800422D0 (en) 1998-04-28
CN1090627C (zh) 2002-09-11
US5968954A (en) 1999-10-19
DE69823411D1 (de) 2004-06-03
HK1014945A1 (en) 1999-10-08
EP0861837A1 (fr) 1998-09-02
AU5635998A (en) 1998-09-03
JPH10237071A (ja) 1998-09-08
BR9800763A (pt) 1999-12-07
CN1194983A (zh) 1998-10-07
CA2231025C (fr) 2003-09-16
FR2760014A1 (fr) 1998-08-28
CA2231025A1 (fr) 1998-08-27
DK0861837T3 (da) 2004-08-16
NO314307B1 (no) 2003-03-03
DE69823411T2 (de) 2005-02-17
ZA981680B (en) 1998-09-04
HUP9800422A1 (hu) 1999-12-28
ATE265451T1 (de) 2004-05-15
NO980803L (no) 1998-08-28
PT861837E (pt) 2004-07-30
EP0861837B1 (fr) 2004-04-28
PL324982A1 (en) 1998-08-31
HU224312B1 (hu) 2005-07-28
AU725756B2 (en) 2000-10-19
PL190240B1 (pl) 2005-11-30
NZ329853A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
DK0428437T3 (da) 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2091834T3 (es) Compuestos aromaticos.
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
NO980803L (no) Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
HRPK20040271B3 (en) Indole derivatives as cox ii inhibitors
HRP20000508B1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
ES2167853T3 (es) N-aril 2-hidroxi alquilamidas.
AU5473596A (en) New indole, indazole benzisoxazole compounds, their process of preparation and the pharmaceutical compositions which contain them
NO165541C (no) Nye azolylderivater, fungicide preparater inneholdende disse som aktiv fugicid bestanddel og anvendelse av azolylderivater for bekjempelse av fungusinfeksjoner i nytteplanter
MX9205921A (es) Derivados de bis(fenil)etano, proceso para su preparacion y composicion farmaceutica que los contiene
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
ATE195936T1 (de) Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung
DK0412015T3 (da) Hidtil ukendte N-(23-vincristinoyl)- og N-(5-noranhydro-23-vinblastinoyl)-1-aminomethylphosphon- syrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
HUP9800687A1 (hu) N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények
AR001786A1 (es) Composición farmacéutica para tratar y prevenir enfermedades mediante la regulación de apoptosis
NO964072D0 (no) Tetrahydronaftofuran- og indanofuranaminforbindelser, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger inneholdende dem